Health Canada
- Status: approved
Use of insulin glargine twice daily (Use of insulin glargine twice daily) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Eastern Virginia Medical School is the originator. The local marketing authorisation holder may differ — check the official source linked above.